Study to Compare MultiHance With Gadovist in Magnetic Resonance Imaging (MRI) of the Brain

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
This study is being conducted as a phase IV, double-blind, multi-center, randomized, crossover trial aimed at a within-subject comparison of MULTIHANCE and GADOVIST at a dose of 0.1 mmol/kg, in terms of qualitative and quantitative assessment of unenhanced MRI (UE MRI) and contrast-enhanced MRI (CE MRI) for the visualization of brain disease.
Epistemonikos ID: 451dc9f32569351e71630d7fef70059f6b1a2668
First added on: May 05, 2024